Avoro Capital Advisors’s Array Biopharma Inc ARRY Stock Holding History

Avoro Capital Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,000,000	Closed	-$92.7M	–	38
2019 Q2	$92.7M	Hold	2,000,000	–	–	3.2%	12
2019 Q1	$48.8M	Buy	+2,000,000	New	+$41.6M	2.11%	15
2018 Q2	–	Sell	-1,922,655	Closed	-$31.4M	–	65
2018 Q1	$31.4M	Sell	1,922,655 -3,545,374	-65%	-$56.8M	1.5%	22
2017 Q4	$70M	Buy	5,468,029 +115,000	+2%	+$1.31M	4.54%	7
2017 Q3	$65.8M	Buy	5,353,029 +1,177,653	+28%	+$10.9M	5.11%	4
2017 Q2	$34.9M	Buy	4,175,376 +395,376	+10%	+$3.23M	4.41%	9
2017 Q1	$33.8M	Buy	3,780,000 +3,620,000	+2,263%	+$38.5M	4.32%	9
2016 Q4	$1.41M	Buy	+160,000	New	+$1.18M	0.28%	34

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Avoro Capital Advisors's ARRY Position: Q3 2019 in Review

Avoro Capital Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,000,000 shares — an estimated $92.7M sold.

Avoro Capital Advisors first reported a position in ARRY in Q4 2016 and held it in 8 quarters. The position peaked at $92.7M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Avoro Capital Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Avoro Capital Advisors sold 2,000,000 Array Biopharma Inc shares in Q3 2019, an estimated $92.7M.
Avoro Capital Advisors first reported a position in Array Biopharma Inc in Q4 2016 and held it in 8 quarters.
Avoro Capital Advisors's Array Biopharma Inc position peaked at $92.7M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Avoro Capital Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.